Cefaclor advanced formulation 750 mg twice daily versus clarithromycin 500 mg twice daily in the treatment of acute maxillary sinusitis

This publication has 10 references indexed in Scilit:

• A Comparison of the Efficacy, Tolerability and Safety of Azithromycin and Co-Amoxiclav in the Treatment of Sinusitis in Adults
  Journal of International Medical Research, 1998
• Comparative Efficacy and Tolerability of Clarithromycin and Cefaclor in the Treatment of Outpatients with Acute Maxillary Sinusitis
  Clinical Drug Investigation, 1997
• Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis.
  Chemotherapy, 1997
• Twice-daily dosing of loracarbef 200 mg versus 400 mg in the treatment of patients with acute maxillary sinusitis
  Clinical Therapeutics, 1995
• Evaluation of Cefixime in the Treatment of Bacterial Maxillary Sinusitis
  Southern Medical Journal, 1993
• The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: A fifteen-year experience at the University of Virginia and review of other selected studies
  Journal of Allergy and Clinical Immunology, 1992
• Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis
  The American Journal of Medicine, 1991
• The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis
  Journal of Antimicrobial Chemotherapy, 1991
• Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative risk
  Statistics in Medicine, 1990
• Sinusitis of the Maxillary Antrum
  New England Journal of Medicine, 1975